US researchers evaluate antidepressant fluvoxamine for Covid-19
UVA researchers test fluvoxamine as a protective measure for patients with Covid-19. Rector and Visitors of the University of Virginia.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more